Compliance

Regulatory readiness backed by disciplined quality systems

We operate a compliance-first model so portfolio onboarding, importation, storage, and distribution activities remain auditable and controlled.

• Document-controlled SOP framework with periodic review and training records
• Batch-level traceability and release governance under QA oversight
• Deviation handling with CAPA ownership and closure verification
• Supplier qualification and dossier intake checks before onboarding
• Cold-chain monitoring controls for relevant products

Laboratory quality testing for compliance and regulatory readiness

Frequently asked compliance questions

Open Verification Hub

How do you support internationally certified manufacturers entering Caribbean markets?

We provide a structured intake process covering dossier readiness, import documentation, regulatory coordination, warehousing controls, and downstream channel planning.

Can you handle both ambient and cold-chain pharmaceutical products?

Yes. Our operating model includes controlled handling pathways, monitoring plans, and escalation procedures for both ambient and temperature-sensitive products.

What compliance documentation is available for due diligence?

We maintain company credentials, SOP registers, QA oversight artifacts, and market-entry readiness documentation available under controlled disclosure.

Do you only distribute finished products?

Our focus is finished dosage distribution, with selective support for hospital and specialty channels based on regulatory pathway suitability.

How quickly can we start a pilot portfolio?

Pilot timelines depend on documentation completeness and filing pathway. Typical onboarding runs in phased milestones with transparent gating criteria.